American Oncology Network Physicians Research is Well Represented at the ASH Annual Meeting & Exposition

/in /by

Fort Myers, Fla., Dec. 16, 2021 – American Oncology Network, LLC (AON) is pleased to announce that eight research studies co-authored by AON physicians were presented at the American Society of Hematology (ASH) Annual Meeting & Exposition, held December 11-14, 2021.

Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 are accepted for oral and poster presentations through an extensive peer review process.

The following AON physician investigators presented their research results during poster discussions and/or presentations.

  • Dr. Ruemu E. Birhiray of Hematology Oncology of Indiana, who served as co-author of a study titled an Extended Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy in the Community-Based United States (US) MM-6 Study: Updated Efficacy and Safety, and Reasons for Premature Discontinuation (Abstract # 2726)
  • Dr. Ralph V. Boccia of The Center for Cancer and Blood Disorders, who served as co-author of several studies titled a Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma (Abstract # 2742) and the Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (Abstract # 2727)
  • Dr. Arvind Chaudhry of Summit Cancer Centers, who presented and served as co-author of several studies titled the Efficacy and Safety of the BTK Inhibitor MK-1026 in Patients with Hematologic Malignancies: Phase 2 Study (Abstract # 3737) and a Phase 2 Study of Zanubrutinib in BTK Inhibitor – Intolerant Patients with Relapsed / Refractory B-Cell Malignancies (Abstract # 1410)
  • Dr. Christopher Chay of Messino Cancer Centers, who served as co-author of a study titled BRUIN MCL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress) (Abstract # 2422)
  • Dr. Victor M. Priego of The Center for Cancer and Blood Disorders, who served as co-author of several studies titled A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies (Abstract # 1355) and Rusfertide (PTG-300), a Hepcidin Mimetic, Maintains Liver Iron Concentration in the Absence of Phlebotomies in Patients with Hereditary Hemochromatosis (Abstract # 943)

AON CEO Todd Schonherz said, “The physicians within our network are dedicated to bringing innovative treatment options to patients, close to home. To have eight AON physicians’ research studies being shared at this prestigious program confirms that our physicians are not only uniting in collaboration, they’re at the forefront of new discoveries and findings that will expand and improve blood disease treatment options for every patient.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network & Partner Oncology
Welcome Weigang Tong, MD, PhD

/in /by

Puyallup, Wash., Dec. 1, 2021 – Drs. Joseph Ye and Xinda David Wang of Partner Oncology (PO) are pleased to announce that Medical Oncologist Weigang Tong, MD, PhD has joined the community oncology practice with locations in Puyallup and Lakewood, Washington. An American Oncology Network, LLC (AON) practice, Partner Oncology provides comprehensive treatment for patients diagnosed with cancer and blood disorders.

Dr. Tong earned his medical degree from West China University of Medical Science and then pursued a PhD in biomedical sciences from Creighton University School of Medicine in Omaha, Neb. He completed two research fellowships in stem cell and leukemia and a fellowship in hematology and oncology from the University of Washington.

“Dr. Tong is joining our community oncology practice because he wants the freedom to care for his patients in a more personalized setting,” said Partner Oncology Medical Oncologist Dr. Joseph Ye. “His approach to patient care is to engage with patients, families and their caregivers to help improve their overall quality of life.”

Dr. Tong treats patients with a broad spectrum of hematology and oncology conditions and has a special interest in malignant hematology, such as leukemia, lymphoma and multiple myeloma. He also has a special interest in gastrointestinal malignancy and breast cancer treatments.

“We are pleased to welcome Dr. Tong to Partner Oncology and AON as he shares our vision of providing high quality cancer care close to where our patients live,” said AON President & Chief Development Officer Brad Prechtl, MBA.

AON Chief Executive Officer Todd Schonherz added, “Dr. Tong forms a special bond with his patients, providing guidance and reassurance while offering them the best possible treatment that is available.”

###

About Partner Oncology: (PartnerOncology.com)
Partner Oncology (PO) offers convenient access to quality cancer and hematology care for patients in Puyallup, Washington. A community-based practice, PO provides medical oncology/hematology services and infusion therapy including immunotherapy for treating cancer and other diseases.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 105 physicians and 79 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

Cancer & Blood Specialists of Arizona Launches the First Local Chapter in Arizona to Advocate for Community Cancer Care

/in /by

Phoenix, Ariz., Nov. 23, 2021 – Cancer & Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network, LLC (AON) launches a new chapter of the Community Oncology Alliance Patient Advocacy Network (CPAN).

CPAN is a national advocacy organization committed to raising awareness of independent, community cancer care and the issues that affect it. CPAN plays a vital role in advocating for patients making sure cancer care is affordable and accessible in the communities where they live.

CBSA Medical Oncologist Tania Cortas, MD, CPE said, “We feel honored to be the first community oncology practice in the entire state of Arizona to partner with CPAN. At Cancer & Blood Specialists of Arizona we pride ourselves on being patient centric and joining this national advocacy group will help our patients to be able to continue to get affordable, yet high-quality cancer care close to where they live.”

“Cancer & Blood Specialists of Arizona patients, survivors, caregivers, family members, physicians, staff and community members can all play a part in helping to influence national policies that can influence cancer care within our community,” said Todd Schonherz, AON Chief Executive Officer.

There are 31 active CPAN chapters across the U.S. advocating in Washington, D.C. to make an impact on influencing policy and expressing the importance of community oncology.

Rose Gerber, Director of Patient Advocacy and Education for CPAN said, “We support the cure but we advocate for the care.” Gerber continued, “Local CPAN chapters within our community cancer centers are important to our cause of educating, engaging and activating cancer care advocates across the nation, helping to ensure patients benefit from quality, affordable and accessible cancer care.”

AON Chief Growth & Relationship Officer Shelly Glenn, added “A CPAN chapter in the Cancer & Blood Specialists of Arizona community means that Greater Phoenix Area patients will have a direct impact on major key cancer issues at a national level.”

CBSA and CPAN will work together to combat issues affecting many patients such as limitations on choice of doctors, less personalized medicine, increased hospital care costs, rising medication prices and being forced to travel for care and treatment.

###

About Cancer & Blood Specialists of Arizona: (CancerBloodSpecialistsAZ.com)
Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix, Arizona, and surrounding areas. Our physicians have deep roots in the Greater Phoenix Area and are proud of our 40-year collective history of delivering the highest quality cancer treatment that is based on cutting-edge research.

About Community Oncology Alliance Patient Advocacy Network (CPAN): (COAAdvoacy.org)
Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix, Arizona, and surrounding areas. Our physicians have deep roots in the Greater Phoenix Area and are proud of our 40-year collective history of delivering the highest quality cancer treatment that is based on cutting-edge research.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network, LLC & Summit Cancer Centers
Welcome Jing Li Huang, MD

/in /by

Fort Myers, Fla., Nov. 19, 2021 – The team of nine medical, surgical and radiation oncologists from Summit Cancer Centers (Summit) welcome Dr. Jing Li Huang to the community oncology practice. Summit, an American Oncology Network, LLC (AON) partner, has eight locations, serving patients in eastern Washington and Idaho.

Dr. Huang is seeing patients in the Spokane Valley, Wash. and Post Falls, Idaho locations. She is Board certified in General Surgery and Board eligible in Complex Surgical Oncology. She earned her medical degree from the University of Rochester School of Medicine and Dentistry, after which she completed her residency in general surgery at the University of Minnesota and specialized training in complex surgical oncology from Roswell Park Comprehensive Cancer Center.

Dr. Huang is skilled in the most advanced treatments, including minimally invasive cancer surgery using the da Vinci robotic-assisted surgical system.

Summit Medical Oncologist Arvind Chaudhry, MD, PhD said, “We continue to add physicians to meet our high standards of delivering the best oncology care. Dr. Huang is experienced in complex oncology surgeries with special interest in cancers that most often affect women including breast and soft tissue sarcomas.”

The Summit team includes Medical Oncologists Arvind Chaudhry, MD, PhD, Bruce Cutter, MD, Carolyn Aks, MD, Stephanie Hodson, MD, Mirela Andrei, MD; Surgical Oncologists Aaron Saunders, MD, MAS, DABS, Max Seaton, MD, Jing Li Huang, MD; and Radiation Oncologists Karie-Lynn Kelly, MD and Jonathan Sharrett, DO.

AON President & Chief Development Officer Brad Prechtl, MBA stated, “Dr. Huang joining the Summit team shows their commitment to enhanced care. Through her extensive training she is able to offer patients multidisciplinary management for the constantly evolving field of oncology care.”

With the addition of Dr. Huang, the Summit team now includes three surgical oncologists, helping to ensure that their patients have access to exceptional cancer care and treatment close to where they live.

“We welcome Dr. Huang and feel privileged to have her on our team. Her approach to treatment is to educate patients to make sure they are making informed decisions based on their specific situation,” added AON Chief Executive Officer Todd Schonherz.

Summit Cancer Centers is a leading cancer center offering multidisciplinary care with comprehensive cancer services from screening and early detection to the most advanced state-of-the-art cancer care available in this region. Cancer treatments include surgical oncology, chemotherapy, immunotherapy and radiation oncology with Cyberknife. Summit is the only oncology practice in this area between Seattle, Salt Lake and Great Falls to offer Cyberknife—innovative outpatient radiation technology.

###

About Summit Cancer Centers: (SummitCancerCenters.com)
Summit Cancer Centers is a community-based medical and surgical oncology practice providing care for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Washington, Idaho, Montana, Oregon and western Canada. Services include diagnostic imaging, nutritional counseling, cancer treatments with the most advanced therapies and technologies and clinical trials to onsite oral chemotherapy and lab services. Additionally, Summit is the only oncology practice in this area (between Seattle, Salt Lake and Great Falls) to offer innovative radiation technology with Cyberknife.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Opens Third Practice in Arizona
with the Addition of Desert Hematology Oncology

/in /by

Fort Myers, Fla., Nov. 9, 2021 – American Oncology Network, LLC (AON), a high-growth national network of independent community oncologists, is pleased to announce the opening of Desert Hematology Oncology in Surprise, Ariz. The community-based practice joined AON effective Nov. 8, 2021 and is now the third practice in Arizona to partner with AON.

Desert Hematology Oncology (DHO) specializes in the diagnosis and treatment of cancer and blood disorders. DHO will offer a variety of services to enhance cancer care by providing an in-house specialty pharmacy and pathology and financial counselors to assist with insurance questions. The clinic is located at 14780 W Mountain View Blvd., Suite 211, Surprise, Ariz.

“Opening Desert Hematology Oncology as our third AON practice in Arizona is helping our mission of ensuring all patients have local access to the best cancer care. High quality, yet affordable care is now a reality for patients living in Surprise, Casa Grande, Phoenix and Gilbert,” said AON President & Chief Development Officer Brad Prechtl, MBA.

Medical Oncologist Dr. David Kahn and Nurse Practitioner Anna Birks will be providing care at DHO. The new clinic will provide infusion therapy, centralized laboratory and pathology and home delivery of oral cancer medications.

AON Chief Executive Officer Todd Schonherz added, “We are excited to have Dr. Kahn join AON, he is an experienced medical oncologist with deep roots in Arizona. He is passionate about research and making sure his patients have access to the latest technologies and treatments available.”

Dr. Kahn emphasized he has a strong history of providing top-quality cancer treatments based on medical evidence and research. “I am focused on the whole person and I value my partnership with each patient and their families.”

AON was founded by well-respected leaders in community oncology with decades of experience helping oncology practices to thrive by providing proven solutions and ensuring that everyone has access to exceptional cancer care.

###

About Desert Hematology Oncology: (DesertHematologyOncology.com)
Desert Hematology Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Offering compassionate and personalized care to patients in Surprise, Ariz., as well as the surrounding Phoenix area. Our Board-certified providers are committed to providing quality, evidence-based oncology and hematology care.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Appoints New Vice President
of Business Development

/in /by

Fort Myers, Fla., Nov. 8, 2021 – American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings, announced that John Misitis has joined as Vice President of Business Development. In his role, Misitis will oversee business development with a primary focus on driving new relationships with providers to join the AON network. In addition to developing and executing plans to grow new business, Misitis will be responsible for maintaining relationships with existing practices to achieve revenue and profitability targets.

Misitis brings over 25 years in sales and business development, along with extensive experience in the physician practice management arena. Most recently he held a leadership position at AmerisourceBergen Oncology Supply, where he was instrumental in significant revenue growth and led critical positioning and sales generation exceeding topline growth of 10% and increasing gross profit by 17% year over year on $7.8B in sales.

In addition to his 13 years tenure with Oncology Supply, he spent 12 years prior with Johnson & Johnson Ortho Biotech serving oncology physician practices in several key roles. Rapidly advancing as part of the leadership team for PROCRIT®, a prescription medicine used to treat anemia, Misitis was responsible for the development and execution of strategies and tactics for sales in community oncology centers plus the long-term care market throughout eight states within the Mid-Atlantic and Eastern regions.

Misitis graduated with a Bachelor of Science in Business Administration and Marketing from Clarion University of Pennsylvania.

“The healthcare landscape is ever-evolving,” said AON Chief Growth & Relationship Officer Shelly Glenn. “John’s experience has ideally positioned him to anticipate future business challenges and proactively develop and implement new growth and diversification initiatives.”

AON Chief Executive Officer Todd Schonherz added: “As we strive to improve care and lower cost, John’s appointment supports our efforts to create an organization that delivers value to our partners, patients and the community. His ability to embrace change and think innovatively will help drive the organization towards improved outcomes helping to make a difference for healthcare providers and patients alike.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network, LLC & Cancer & Blood Specialists of Arizona Welcome Amber Flaherty, MD

/in /by

Phoenix, Ariz., Nov. 1, 2021 – Drs. Snehal Bhoola, Tania Cortas, Mazen Khattab, Shana Wingo and Harshita Paripati of Cancer & Blood Specialists of Arizona (CBSA) welcome Medical Oncologist/Hematologist Amber Flaherty, MD to the community oncology practice. CBSA, an American Oncology Network, LLC (AON) partner, has three locations in the Greater Phoenix Area including the Northwest, East Valley and Phoenix/Scottsdale.

Dr. Flaherty is seeing patients in Phoenix/Scottsdale at 11209 N. Tatum Blvd, Suite B200 in Phoenix. She is a Board-certified medical oncologist and hematologist who treats patients with all cancer types and blood disorders, and specializes in genitourinary cancers focused on the kidney, bladder and prostate.

Dr. Flaherty earned her medical degree from St. George’s University Grenada, West Indies. She completed her residency in internal medicine at the University of Texas Health Science Center in Houston followed by fellowship training in hematology and oncology at Moffitt Cancer Center in Tampa, Fla.

Dr. Tania Cortas of Cancer & Blood Specialists of Arizona said, “Dr. Flaherty will be an asset to our team as she brings with her a passion for cancer research and has participated in several studies as the principal investigator.”

“The CBSA team is growing to meet the needs of our patients in the Phoenix area,” said AON President & Chief Development Officer Brad Prechtl, MBA. “With the addition of Dr. Flaherty, CBSA will now include four medical oncologists and two gynecologic oncologists helping to provide personalized care conveniently located close to home.”

Through its partnership with AON, CBSA offers state-of-the-art technology and the latest advances in clinical research and therapies, home delivery of oral oncolytic medications, 24/7 pharmacy assistance and pathology and laboratory services.

AON Chief Executive Officer Todd Schonherz, added “Dr. Flaherty is known for her customized approach to treatment, she takes the time to get to know her patients and their families to develop a plan that is best suited for them with the focus on enhancing their quality of life.”

###

About Cancer & Blood Specialists of Arizona: (CancerBloodSpecialistsAZ.com)
Cancer & Blood Specialists of Arizona is a community-based Medical Oncology, Gynecologic Oncology and Hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. We are experienced physicians, nurse practitioners, nurses and clinical support staff providing compassionate, patient-centered care in Phoenix, Arizona, and surrounding areas. Our physicians have deep roots in the Greater Phoenix Area and are proud of our 40-year collective history of delivering the highest quality cancer treatment that is based on cutting-edge research.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network Expands Footprint in Arizona
with the Addition of Pinal Cancer & Surgery Center

/in /by

Fort Myers, Fla., Nov. 1, 2021 – American Oncology Network, LLC (AON), a high-growth national network of independent community oncologists, is pleased to announce that Pinal Cancer & Surgery Center in Casa Grande, Ariz., formerly Alliance Cancer Care and Alliance Surgery Arizona, joined AON effective November 1, 2021. This community-based practice is now the second practice in Arizona to partner with AON.

Pinal Cancer & Surgery Center (PCSC) provides general and oncology surgery specializing in minimally invasive, minor and major surgical conditions, as well as radiation oncology and medical oncology/hematology treatments and services for patients diagnosed with cancer and blood disorders. Making care easily accessible for patients, the cancer clinic and the surgery center are both conveniently located in Casa Grande.

PCSC treats a wide variety of tumor types while offering personalized care customized for each patient. Additionally, patients will have access to centralized laboratory and pathology, home delivery of oral cancer medications and care management support.

“We welcome Drs. Carlos Arce-Lara and Ramon Mourelo to our growing network of community oncology practices,” said AON President & Chief Development Officer Brad Prechtl, MBA. “The physicians and staff at Pinal Cancer & Surgery Center have an excellent reputation in the community and are truly dedicated to providing patients with comprehensive, integrated care.”

AON Chief Executive Officer Todd Schonherz added, “We have an expanding presence in Arizona. With the addition of this practice, we now have two additional community oncology clinics offering cancer patients care, close to home.”

“We are excited to partner with AON to provide innovative cancer care while offering our patients enhanced services that will improve their overall health during their cancer journey,” said PCSC Medical Oncologist & Hematologist Carlos Arce-Lara, MD.

AON was founded by well-respected leaders in community oncology with decades of experience helping oncology practices to thrive by providing proven solutions and ensuring that everyone has access to exceptional cancer care.

###

About Pinal Cancer & Surgery Center: (PinalCancerSurgery.com)
Pinal Cancer & Surgery Center (PCSC) specializes in the diagnosis and treatment of blood disorders and cancer. Our goal is to renew your hope in the future by providing professional and compassionate medical care close to home. The main clinic location and surgery center are in Casa Grande, Ariz. PCSC has a highly skilled team that works together at every stage of the diagnosis offering personalized cancer treatment to help make the best decisions in the fight against cancer

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 104 physicians and 78 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of  Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network In-House Specialty Pharmacy Earns Third Accreditation

/in /by

Fort Myers, Fla., Oct. 25, 2021 – The American Oncology Network, LLC (AON) in-house specialty pharmacy is pleased to announce their recent accreditations by the National Association of Boards of Pharmacy® (NABP®) for specialty pharmacy practice and for digital pharmacy practice. Already accredited with ACHC (Accreditation Commission for Health Care) and URAC (Utilization Review Accreditation Commission), the addition of the NABP accreditation makes three pharmacy accreditations in total, well above industry standards.

AON Sr. Pharmacy Director Douglas Braun, CSP, PharmD, RPh said, “Specialty pharmacies are in the care management business and the evolving role of specialty pharmacies in serving patients with complex, chronic diseases is critical to improving patient outcomes.”

NABP’s Specialty Pharmacy Accreditation signifies to patients, payers, and providers that the pharmacy organization is recognized for providing an advanced level of pharmacy services and disease management for patients taking medications that require special handling, storage and distribution requirements. Specialty pharmacies coordinate patient education, promote adherence and ensure appropriate medication use.

NABP’s Digital Pharmacy Accreditation signifies the pharmacy organization is recognized for its commitment to quality health care and safe pharmacy practices over the internet. The thorough review process included an on-site survey and the website was verified to review the pharmacy’s online presence and medication-related websites to ensure that they are properly licensed and follow applicable laws and business best practices.

This voluntary accreditation process demonstrates compliance to a comprehensive set of practice standards and evaluated the pharmacy on practice management, patient care services, and quality improvement. “NABP congratulates the AON Pharmacy on achieving this important recognition,” says NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh. “By earning Specialty Pharmacy Accreditation, they demonstrate their commitment to quality health care and patient safety, that improve overall health outcomes.”

“Specialty pharmacies that achieve accreditation demonstrate the highest value in delivering enhanced clinical services,” added AON Chief Executive Officer Todd Schonherz. “Many will attempt for dual accreditation but very few achieve triple accreditation, so we are very proud of this accomplishment.”

AON Chief Pharmacy & Procurement Officer James Gilmore stated, “Obtaining accreditation from three different governing bodies demonstrates AON’s commitment to excellence and our ability to provide superior care to our patients.”

###

About the National Association of Boards of Pharmacy (NABP.pharmacy.com)
The National Association of Boards of Pharmacy (NABP) is the impartial professional organization that supports its member regulatory state boards of pharmacy in creating uniform regulations to protect public health. Founded in 1904, NABP aims to ensure the public’s health and safety through its pharmacist competence assessment programs, license transfer and verification services, as well as through pharmacy inspection and accreditation programs. For more information, please visit www.nabp.pharmacy.

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly growing AON network represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON brings more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

For More Information, Contact:
American Oncology Network, LLC
Caroline Hewitt, Vice President of Marketing
Caroline.Hewitt@AONcology.com

American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute

/in /by

Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 — American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site. Hematology/Oncology Clinic in Baton Rouge, La., Messino Cancer Centers in Asheville, N.C., and Zangmeister Cancer Center in Columbus, Ohio, all partner practices of AON, are also strategic research sites under this partnership, which brings greater access to cutting-edge therapies through clinical trials for patients.

For close to 30 years, Genesis has been participating in clinical trials. This new partnership with Sarah Cannon Research Institute will provide patients access to an expanded menu of clinical trials and advanced therapies. Genesis Medical Oncologists serving patients in Hot Springs are Dr. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. Lynn Cleveland and Dr. Lingyi Chen.

“The physicians at Genesis Cancer and Blood Institute are committed to delivering advanced treatment options for the best possible outcomes for their patients,” said AON CEO Todd Schonherz. “By partnering with Sarah Cannon Research Institute, we are combining our exceptional local physician expertise with internationally-recognized teams and research to improve care and match patients with potentially life-saving treatments while staying within the comfort and familiarity of their oncologist’s office.”

AON Vice President of Clinical Research Katie Goodman added, “In the world of oncology, clinical research is a major force in the advancement of treatments for different cancers. Clinical trials also help us improve the quality of life for patients during and after treatment.”

AON is currently comprised of an expanding network of partner practices across 17 states. AON practices offer in-house laboratory, pathology and oral pharmacy services all under one roof so that patients can receive the care they need in one location. Research has shown that having easy and convenient access to expert physician care and a comprehensive range of treatments and support services close to home is vital to a patient’s well-being. By collaborating with Sarah Cannon Research Institute, which is a global leader in offering community-based clinical trials, AON is providing opportunities for patients to participate in cutting-edge cancer research, while reducing the need to drive long distances or travel out of state for care.

Sarah Cannon Research Institute pioneered the first community-based oncology drug development program in the United States and has grown to become a global leader in early phase research, conducting more than 500 first-in-human studies to date. Through its efforts to advance therapies for patients, Sarah Cannon Research Institute has been a clinical trial leader in the majority of approved cancer therapies over the last decade.

“Through our partnership with AON, we are furthering our mission to bring cutting-edge therapies into the community so patients can stay close to home while accessing the treatment options they need,” said Howard A. “Skip” Burris, III, MD, President of Clinical Operations and Chief Medical Officer at Sarah Cannon. “We look forward to working together with the experts at Genesis Cancer and Blood Institute to offer clinical trials for people facing cancer in Hot Springs.”

###

About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network currently represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.

About Sarah Cannon Research Institute: (SarahCannon.com)
Sarah Cannon Research Institute is the research arm of HCA Healthcare’s Cancer Institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. A leader in drug development, Sarah Cannon has led more than 500 first-in-human clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Additionally, Sarah Cannon offers management, regulatory, and other research support services for drug development and industry sponsors as well as strategic investigator sites through its contract research organization (CRO), Sarah Cannon Development Innovations.

For More Information, Contact:
Caroline Hewitt
Vice President of Marketing, American Oncology Network, LLC 
Caroline.Hewitt@AONcology.com

Sarah Cannon Research Institute
Samantha Maxwell
Samantha.Maxwell@sarahcannon.com